To date there have been several studies indicating C-reactive protein-to-albumin Ratio (CRP/ALB, CAR) as a chronic inflammatory ratio has potential use in both IBD diagnostics (5) and many types of cancer prognostication (6). This evidence concerns the gene CRP and inflammatory bowel disease.